Hepatitis B and C virus infection in Crohn's disease

Inflammatory Bowel Diseases

Volumn 7, Issue 4, 2001, Pages 287-294

  Biancone, Livia ^a   Pavia, Maria ^b   Del Vecchio Blanco, Giovanna ^a   D'Incà, Renata ^c   Castiglione, Fabiana ^d   De Nigris, Francesca ^a   Doldo, Patrizia ^b   Cosco, Cristina ^b   Vavassori, Piero ^a   Bresci, Giampaolo P ^e   Arrigoni, Arrigo ^f   Cadau, Giuseppina ^g   Monteleone, Ivan ^a   Rispo, Antonio ^d   Fries, Walter ^h   Mallardi, Bruna ⁱ   Sturniolo, Giancarlo C ^b   Pallone, Francesco ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY HOSPITAL OF PISA   (Italy)

^f MOLINETTE HOSPITAL   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Crohn's disease; Hepatitis B virus infection; Hepatitis C virus infection; Immunomodulatory drugs; Interferon ; Risk factors

Indexed keywords

ALPHA INTERFERON; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOMODULATING AGENT; VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CROHN DISEASE; DISEASE CONTROL; DISEASE COURSE; ENDOSCOPY; FEMALE; GENDER; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOST; HUMAN; IMMUNE RESPONSE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SERUM; SURGERY; ULCERATIVE COLITIS;

EID: 0035158696     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200111000-00002     Document Type: Article

References (42)

1. Screening and shouting about HCV
2. Epidemiology of hepatitis C
3. Prevalence, risk factors and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in Southern Italy
4. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: A multicenter Italian study
5. The etiology of chronic hepatitis in Italy: Multicenter study
6. Changing epidemiology of hepatitis B in Italy: Public health implications
7. Hepatitis B: An important public health issue
8. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
9. Analysis of clinical course of postoperative recurrence in Crohn's disease
10. Surgical procedures as a major risk factor for chronic hepatitis C virus infection in Italy: Evidence from a case-control study
11. Prevalence of hepatitis C in patients with chronic inflammatory bowel disease in the region of Nice and evaluation of risk factors
12. Onset of celiac disease during treatment with interferon for chronic hepatitis C
13. Role of interferon-alpha in promoting T helper cell type 1 responses in the small intestine in celiac disease
14. Interleukin-12 (IL-12) is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
15. Interleukin 12 and Th1 responses in inflammatory bowel disease
16. Bioactive IL-18 expression is up-regulated in Crohn's disease
17. Inflammatory bowel disease: Etiology and pathogenesis
18. Hepatitis G virus: Molecular organization, methods of detection, prevalence and disease association
19. Histological grading and staging of chronic hepatitis
20. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysos study
21. Prevalence of chronic liver disease in the general population of Northern Italy: The Dionysos Study
22. High prevalence of hepatitis C virus infection in a small central Italian town: Lack of evidence of parenteral exposure
23. Impact of hepatitis C virus infection on healthy subjects on an Italian island
24. Low prevalence of anti-HCV antibody among Italian children
25. Epidemiology of viral hepatitis B in Italy
26. High incidence of hepatitis B infections among chronic hepatitis cases of unknown etiology
27. Th1/Th2 cells
28. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C infection and rejection
29. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection
30. Role of the specific T-cell response for clearance and control of hepatitis C virus
31. The hepatitis C virus (HCV) induces a long-term increase in interleukin-10 production by human CD4+ T cells (H9)
32. Celiac sprue: Another autoimmune syndrome associated with hepatitis C
33. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder
34. Cytokine gene polymorphisms in psoriasis
35. Hepatitis C virus antibody (anti-HCV): Prevalence in psoriasis
36. Psoriasis and hepatitis C virus
37. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives
38. Effect of short-term prednisone therapy on aminotrasferase levels and hepatitis B virus markers in chronic type B hepatitis
39. Exacerbation of chronic active hepatitis B after short-term corticosteroid therapy resulting in fatal liver failure
40. Short-term prednisone therapy affects aminotrasferase activity and hepatitis C virus RNA levels in chronic hepatitis C
41. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection
42. Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis